OPTOMED.HEOPTOMED.HEHEL
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+78.3%
5Y CAGR-3.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+78.3%/yr
Quarterly compound
5Y CAGR
-3.1%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 409.09% |
| Q3 2025 | -41.07% |
| Q2 2025 | -64.10% |
| Q1 2025 | 48.57% |
| Q4 2024 | 72.13% |
| Q3 2024 | 17.31% |
| Q2 2024 | -34.18% |
| Q1 2024 | 83.72% |
| Q4 2023 | -20.37% |
| Q3 2023 | 25.58% |
| Q2 2023 | -90.36% |
| Q1 2023 | 619.35% |
| Q4 2022 | 72.22% |
| Q3 2022 | -56.10% |
| Q2 2022 | -85.98% |
| Q1 2022 | 8.33% |
| Q4 2021 | 16.13% |
| Q3 2021 | -28.57% |
| Q2 2021 | 3.66% |
| Q1 2021 | -61.04% |
| Q4 2020 | 477.78% |
| Q3 2020 | -24.39% |
| Q2 2020 | -28.35% |
| Q1 2020 | -65.51% |
| Q4 2019 | 254.63% |
| Q3 2019 | -12.29% |
| Q2 2019 | 31.87% |
| Q1 2019 | -72.42% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |